UBS Group’s Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 ATA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-9,129
Closed -$1K 11659
2022
Q3
$1K Hold
9,129
﹤0.01% 10223
2022
Q2
$0 Buy
9,129
+6,516
+249% +$590 ﹤0.01% 11499
2022
Q1
$0 Buy
+2,613
New +$640 ﹤0.01% 11373

UBS Group's ATA.WS Position: Q4 2022 in Review

UBS Group sold out of Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 (ATA.WS) in Q4 2022, closing a stake of 9,129 shares — an estimated $1K sold.

UBS Group first reported a position in ATA.WS in Q1 2022 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 0 funds tracked by Wall St. Rank hold ATA.WS as of Q4 2022.

  • UBS Group reported no remaining Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 9,129 Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 shares in Q4 2022, an estimated $1K.
  • UBS Group first reported a position in Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 in Q1 2022 and held it in 3 quarters.
  • UBS Group's Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 position peaked at $1K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.